NCT02213913 2026-03-11Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasUniversity of ChicagoPhase 1/2 Completed55 enrolled 17 charts
NCT01542918 2020-08-11Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular LymphomaUniversity of California, San FranciscoPhase 1 Completed14 enrolled
NCT01254578 2017-09-25Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersNational Cancer Institute (NCI)Phase 1 Completed17 enrolled